| 11/18/2026 4:07 PM | Teva Pharmaceutical Industries (818686) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/16/2026 1:40 PM | Phoenix Financial Ltd. (1679543) Filed by Teva Pharmaceutical Industries (818686) Subject | Form SCHEDULE 13G/A | |
| 11/12/2026 3:08 PM | Bergwerk Dov (1997381) Reporting Teva Pharmaceutical Industries (818686) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/12/2026 3:10 PM | Teva Pharmaceutical Industries (818686) Issuer Weiss Amir (1897057) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/12/2026 3:12 PM | Sabag Mark (1721442) Reporting Teva Pharmaceutical Industries (818686) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/12/2026 5:09 AM | Daniell Richard (1726096) Reporting Teva Pharmaceutical Industries (818686) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/10/2026 11:38 AM | MENORA MIVTACHIM HOLDINGS LTD. (1351917) Filed by Teva Pharmaceutical Industries (818686) Subject | Form SCHEDULE 13G/A | |
| 11/03/2026 3:06 PM | Teva Pharmaceutical Industries (818686) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 11/03/2026 7:08 AM | Teva Pharmaceutical Industries (818686) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/02/2026 5:17 AM | Harel Insurance Investments & Financial Services Ltd. (1429390) Filed by Teva Pharmaceutical Industries (818686) Subject | Form SCHEDULE 13G/A | |
| 10/29/2026 4:08 PM | Teva Pharmaceutical Industries (818686) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for TEVA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Teva Pharmaceutical Industries and its competitors with MarketBeat's FREE daily newsletter.
|
| 10/08/2026 3:01 PM | Bergwerk Dov (1997381) Reporting Teva Pharmaceutical Industries (818686) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 09/22/2026 4:01 PM | Savage Brian (2112339) Reporting Teva Pharmaceutical Industries (818686) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/22/2026 3:21 PM | MIGNONE ROBERTO (1258394) Reporting Teva Pharmaceutical Industries (818686) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/21/2026 5:40 AM | Savage Brian (2112339) Reporting Teva Pharmaceutical Industries (818686) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/18/2026 4:00 PM | BRIDGER MANAGEMENT, LLC (1166309) Reporting Teva Pharmaceutical Industries (818686) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/16/2026 3:25 PM | Teva Pharmaceutical Industries (818686) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/14/2026 3:05 PM | Teva Pharmaceutical Industries (818686) Filer | Form 8-A12B/A | |
| 09/14/2026 3:06 PM | Teva Pharmaceutical Industries (818686) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/14/2026 1:32 PM | NEW YORK STOCK EXCHANGE LLC (876661) Filed by Teva Pharmaceutical Industries (818686) Subject | Form 25-NSE | |
| 09/11/2026 4:05 PM | Teva Pharmaceutical Finance Netherlands II B.V. (1628587) Filer Teva Pharmaceutical Finance Netherlands III B.V. (1679183) Filer Teva Pharmaceutical Finance Netherlands IV B.V. (1679174) Filer Teva Pharmaceutical Industries (818686) Filer | Form 424B5 | |
| 09/11/2026 3:05 PM | Teva Pharmaceutical Industries (818686) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/10/2026 5:01 AM | Teva Pharmaceutical Industries (818686) Subject | Form FWP | |
| 09/10/2026 5:04 AM | Teva Pharmaceutical Industries (818686) Subject | Form FWP | |
| 09/08/2026 5:54 AM | Teva Pharmaceutical Industries (818686) Filer | Form 424B5 | |
| 09/03/2026 3:06 PM | Teva Pharmaceutical Industries (818686) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/25/2026 3:03 PM | Satchi-Fainaro Ronit (1742782) Reporting Teva Pharmaceutical Industries (818686) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/25/2026 3:05 PM | Teva Pharmaceutical Industries (818686) Issuer Weiss Amir (1897057) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/19/2026 3:00 PM | Lippman Evan (2062834) Reporting Teva Pharmaceutical Industries (818686) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/10/2026 5:07 AM | Teva Pharmaceutical Industries (818686) Issuer Zaks Tal Zvi (1690927) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/03/2026 3:01 PM | Hughes Eric A (1938678) Reporting Teva Pharmaceutical Industries (818686) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/22/2026 3:00 PM | Shields Matthew (2025621) Reporting Teva Pharmaceutical Industries (818686) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/16/2026 7:28 AM | Kalif Eliyahu Sharon (1798443) Reporting Teva Pharmaceutical Industries (818686) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/11/2026 3:00 PM | Kalif Eliyahu Sharon (1798443) Reporting Teva Pharmaceutical Industries (818686) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/08/2026 3:01 PM | Francis Richard D (1673277) Reporting Teva Pharmaceutical Industries (818686) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/08/2026 3:02 PM | MIGNONE ROBERTO (1258394) Reporting Teva Pharmaceutical Industries (818686) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/08/2026 3:03 PM | Teva Pharmaceutical Industries (818686) Issuer Zaks Tal Zvi (1690927) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/08/2026 3:03 PM | Satchi-Fainaro Ronit (1742782) Reporting Teva Pharmaceutical Industries (818686) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/08/2026 3:04 PM | Nisen Perry (1683791) Reporting Teva Pharmaceutical Industries (818686) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/08/2026 3:04 PM | LIEBERMAN GERALD M (1234346) Reporting Teva Pharmaceutical Industries (818686) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/08/2026 3:05 PM | Elstein Amir (1721354) Reporting Teva Pharmaceutical Industries (818686) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
I'm handing you this stock today (Ad) Elon doesn't own the chip inside his Teslas or Starlink dishes. He licenses it from one little known public company.
Now he's planning 1,000,000 AI satellites in orbit, and every one could pay this company a royalty.
Analyst Dylan says the window to get in closes around December 8th, before new money floods into the buildout. Download this free stock pick before December 8th arrives |
| 06/08/2026 3:06 PM | Crane Rosemary A (1443343) Reporting Teva Pharmaceutical Industries (818686) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/08/2026 3:06 PM | Lichtenstein Chen (2046465) Reporting Teva Pharmaceutical Industries (818686) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/08/2026 3:07 PM | BARER SOL J (1247015) Reporting Teva Pharmaceutical Industries (818686) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/04/2026 3:00 PM | Shields Matthew (2025621) Reporting Teva Pharmaceutical Industries (818686) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/03/2026 2:59 PM | Shields Matthew (2025621) Reporting Teva Pharmaceutical Industries (818686) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/01/2026 3:16 PM | Teva Pharmaceutical Industries (818686) Issuer Zaks Tal Zvi (1690927) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/01/2026 3:03 PM | BARER SOL J (1247015) Reporting Teva Pharmaceutical Industries (818686) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/28/2026 3:05 PM | Teva Pharmaceutical Industries (818686) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/18/2026 3:02 PM | Lippman Evan (2062834) Reporting Teva Pharmaceutical Industries (818686) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/07/2026 3:03 PM | Teva Pharmaceutical Industries (818686) Issuer Weiss Amir (1897057) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/04/2026 7:12 AM | Sabag Mark (1721442) Reporting Teva Pharmaceutical Industries (818686) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 04/29/2026 6:00 AM | Teva Pharmaceutical Industries (818686) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/31/2026 3:38 PM | Teva Pharmaceutical Industries (818686) Filer | Form DEF 14A | |
| 03/31/2026 3:41 PM | Teva Pharmaceutical Industries (818686) Filer | Form ARS | |
| 03/31/2026 3:43 PM | Teva Pharmaceutical Industries (818686) Filer | Form DEFA14A | |
| 03/19/2026 3:01 PM | Sabag Mark (1721442) Reporting Teva Pharmaceutical Industries (818686) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/09/2026 3:22 PM | Kalif Eliyahu Sharon (1798443) Reporting Teva Pharmaceutical Industries (818686) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/09/2026 3:23 PM | Sabag Mark (1721442) Reporting Teva Pharmaceutical Industries (818686) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/09/2026 3:14 PM | Hughes Eric A (1938678) Reporting Teva Pharmaceutical Industries (818686) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/09/2026 3:16 PM | Fox Christine (1998173) Reporting Teva Pharmaceutical Industries (818686) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/09/2026 3:18 PM | Francis Richard D (1673277) Reporting Teva Pharmaceutical Industries (818686) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/09/2026 3:19 PM | Teva Pharmaceutical Industries (818686) Issuer Weiss Amir (1897057) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/09/2026 3:09 PM | Savage Brian (2112339) Reporting Teva Pharmaceutical Industries (818686) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/09/2026 3:10 PM | Jover Placid (2026165) Reporting Teva Pharmaceutical Industries (818686) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/09/2026 3:12 PM | Daniell Richard (1726096) Reporting Teva Pharmaceutical Industries (818686) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 3:11 PM | Lippman Evan (2062834) Reporting Teva Pharmaceutical Industries (818686) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 3:13 PM | Sabag Mark (1721442) Reporting Teva Pharmaceutical Industries (818686) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 3:14 PM | Shields Matthew (2025621) Reporting Teva Pharmaceutical Industries (818686) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 3:05 PM | Fox Christine (1998173) Reporting Teva Pharmaceutical Industries (818686) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 3:08 PM | Kalif Eliyahu Sharon (1798443) Reporting Teva Pharmaceutical Industries (818686) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 3:09 PM | Hughes Eric A (1938678) Reporting Teva Pharmaceutical Industries (818686) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/05/2026 4:39 PM | Savage Brian (2112339) Reporting Teva Pharmaceutical Industries (818686) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/05/2026 4:43 PM | Jover Placid (2026165) Reporting Teva Pharmaceutical Industries (818686) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/05/2026 4:49 PM | Shields Matthew (2025621) Reporting Teva Pharmaceutical Industries (818686) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/05/2026 4:26 PM | Francis Richard D (1673277) Reporting Teva Pharmaceutical Industries (818686) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/05/2026 4:32 PM | Fox Christine (1998173) Reporting Teva Pharmaceutical Industries (818686) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/05/2026 4:08 PM | Daniell Richard (1726096) Reporting Teva Pharmaceutical Industries (818686) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/05/2026 4:13 PM | Hughes Eric A (1938678) Reporting Teva Pharmaceutical Industries (818686) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/05/2026 3:09 PM | Daniell Richard (1726096) Reporting Teva Pharmaceutical Industries (818686) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/05/2026 3:11 PM | Teva Pharmaceutical Industries (818686) Issuer Weiss Amir (1897057) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/04/2026 4:42 PM | Fox Christine (1998173) Reporting Teva Pharmaceutical Industries (818686) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/04/2026 4:28 PM | Hughes Eric A (1938678) Reporting Teva Pharmaceutical Industries (818686) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/04/2026 4:36 PM | Francis Richard D (1673277) Reporting Teva Pharmaceutical Industries (818686) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/03/2026 4:34 PM | Francis Richard D (1673277) Reporting Teva Pharmaceutical Industries (818686) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/03/2026 4:46 PM | Savage Brian (2112339) Reporting Teva Pharmaceutical Industries (818686) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/03/2026 4:25 PM | Hughes Eric A (1938678) Reporting Teva Pharmaceutical Industries (818686) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/02/2026 3:01 PM | Kalif Eliyahu Sharon (1798443) Reporting Teva Pharmaceutical Industries (818686) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/26/2026 3:11 PM | Kalif Eliyahu Sharon (1798443) Reporting Teva Pharmaceutical Industries (818686) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/18/2026 5:28 AM | Francis Richard D (1673277) Reporting Teva Pharmaceutical Industries (818686) Subject | Form 144/A | |
| 02/18/2026 5:12 AM | Francis Richard D (1673277) Reporting Teva Pharmaceutical Industries (818686) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
ELON + YOU + DECEMBER 8TH (Ad) Elon Musk's next big project may be the most ambitious move of his career, and all signs point to December 8th.
A free Masterclass claims to reveal what Musk filed with regulators and why he's working to keep it quiet. Watch the free Masterclass now to learn what happens on December 8th |
| 02/17/2026 10:05 AM | Migdal Insurance & Financial Holdings Ltd. (1415912) Filed by Teva Pharmaceutical Industries (818686) Subject | Form SCHEDULE 13G | |
| 02/09/2026 5:03 AM | Harel Insurance Investments & Financial Services Ltd. (1429390) Filed by Teva Pharmaceutical Industries (818686) Subject | Form SCHEDULE 13G/A | |
| 02/03/2026 7:58 AM | Teva Pharmaceutical Industries (818686) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 01/28/2026 6:20 AM | Teva Pharmaceutical Industries (818686) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/12/2026 5:00 AM | Teva Pharmaceutical Industries (818686) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/12/2025 3:17 PM | BRIDGER MANAGEMENT, LLC (1166309) Reporting Teva Pharmaceutical Industries (818686) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/11/2025 3:31 PM | Teva Pharmaceutical Industries (818686) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/09/2025 3:03 PM | Sabag Mark (1721442) Reporting Teva Pharmaceutical Industries (818686) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/09/2025 3:00 PM | Daniell Richard (1726096) Reporting Teva Pharmaceutical Industries (818686) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |